Baldo A, Sniderman A D, St-Luce S, Avramoglu R K, Maslowska M, Hoang B, Monge J C, Bell A, Mulay S, Cianflone K
McGill Unit for the Prevention of Cardiovascular Disease, Royal Victoria Hospital, Montreal, Quebec, Canada.
J Clin Invest. 1993 Sep;92(3):1543-7. doi: 10.1172/JCI116733.
We have previously characterized an activity from human plasma that markedly stimulates triglyceride synthesis in cultured human skin fibroblasts and human adipocytes. Based on its in vitro activity we named the active component acylation stimulating protein (ASP). The molecular identity of the active serum component has now been determined. NH2-terminal sequence analysis, ion spray ionization mass spectroscopy, and amino acid composition analysis all indicate that the active purified protein is a fragment of the third component of plasma complement, C3a-desArg. As well, reconstitution experiments with complement factors B, D, and complement C3, the components necessary to generate C3a, have confirmed the identity of ASP as C3a. ASP appears to be the final effector molecule generated by a novel regulatory system that modulates the rate of triglyceride synthesis in adipocytes.
我们之前已对一种来自人血浆的活性物质进行了特性描述,该物质能显著刺激培养的人皮肤成纤维细胞和人脂肪细胞中的甘油三酯合成。基于其体外活性,我们将该活性成分命名为酰化刺激蛋白(ASP)。现在已确定了活性血清成分的分子身份。氨基末端序列分析、离子喷雾电离质谱分析和氨基酸组成分析均表明,纯化后的活性蛋白是血浆补体第三成分C3a-去精氨酸的一个片段。此外,用补体因子B、D以及补体C3(生成C3a所需的成分)进行的重组实验,证实了ASP就是C3a。ASP似乎是一种新型调节系统产生的最终效应分子,该调节系统可调节脂肪细胞中甘油三酯的合成速率。